Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2Breast Neoplasms 2Vitamin D Deficiency 1Rectal Neoplasms 1Insulin Resistance 1Inflammation 1Giant Cell Tumor of Bone 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognitive Dysfunction 1Bone Diseases 1Biomarker Change Linked to Breast Cancer 1

Interventions

Vitamin D 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Giant Cell Tumor of Bone × Vitamin D × Clear all
NCT04255576 2022-10-14

Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone

Shanghai JMT-Bio Inc.

Phase 1/2 Unknown
139 enrolled

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡